Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)
Clinical trial NCT01597505 · COMPLETED
Trial details
- NCT number
- NCT01597505
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-16
- Primary completion
- 2015-03-20
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.